Caris & Co Downgrades Shire Ltd. (SHPGY) to Average
More News related to SHPGY
- Shire to Present Important Study Findings for Gaucher Disease Treatment and GLD Development Program at the Lysosomal Disease Network (LDN) World Symposium
- Exane BNP Paribas Upgrades Biotechnology and Drugs Stocks SNY & SHPGY to Outperform
- Notable Analyst Rating Changes 01/20: KELYA, CBS, SHPGY, SWIR, IBM Upgraded; TSCO, BIG, AAP, VRS, CPO Downgraded
- J.P. Morgan Upgrades Shire plc (SHPGY) to Overweight
- Jefferies & Co Upgrades Shire plc (SHPGY) to Buy
More News related to Downgrades
- S&P Lowers Pinnacle Entertainment (PNK) Outlook from Stable to Negative
- Mindspeed (MSPD) Moving Lower as Brigantine Downgrades to Hold
- Davenport Downgrades Electronic Arts (ERTS) to Sell; Lowers Q4, 2010-11 Estimates
- Stifel Nicolaus Downgrades Parkway Properties (PKY) to Sell
- Craig-Hallum Downgrades Terremark (TMRK) to Accumulate
Caris & Co downgrades Shire Ltd. (Nasdaq: SHPGY) from Above Average to Average. Price target $55.
To see more analyst ratings on SHPGY Click Here.
Related Categories
DowngradesStocks Mentioned
+0.80Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
